Paradoxically, both the circulating and tissue (e.g., liver, skeletal muscle, and AT) levels of FGF21 are elevated under nutrient-excess states such as obesity (319), suggesting the presence of FGF21 resistance (320) or an adaptive response in obesity. This evidence concerns the gene FGF21 and obesity disorder.